<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Holzmeister, Johannes</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">No Improvement with CRT in Patients with HF and QRS </style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">23-24</style></pages><abstract><style  face="normal" font="default" size="100%">Although cardiac resynchronization therapy (CRT) is not currently recommended for heart failure (HF) patients with a QRS complex &lt;120 msec, many such patients have evidence of mechanical dyssynchrony by echocardiography. The Echocardiography Guided Cardiac Resynchronization Therapy study [EchoCRT; Ruschitzka F et al. N Engl J Med 2013] was a prospective, multicenter, randomized, clinical trial designed to evaluate the effect of CRT on morbidity and mortality in patients with symptomatic HF, a QRS complex &lt;130 msec, and evidence of mechanical dyssynchrony.</style></abstract><number><style face="normal" font="default" size="100%">15</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>